Last updated 2026-07-20
Portfolio
1
in our dataset
Rounds participated
2
Rounds led
1
Rounds' value
$20.0M
total disclosed, rounds participated
Stages
—
About
REV Venture Partners (formerly Reed Elsevier Ventures) is a corporate venture capital firm founded in 2000 and backed by RELX Group. They invest in early to mid-stage internet, media, and technology companies, with a focus on big data, analytics, healthcare information, software, mobile platforms and applications, and business and consumer internet sectors. They typically lead rounds with initial investments between $1-$10 million and take active board seats. REV Venture Partners has a global presence, including an active presence in Tel Aviv.
Portfolio · 1
Investment activity
Portfolio by sector
Health Tech & Life Sciences1
Q&A
- What is Reed Elsevier Ventures' primary sector focus?
- Reed Elsevier Ventures has shown a concentration in the Health Tech & Life Sciences sector, with all of its portfolio companies and investment rounds falling within this area.
- Can you name a notable portfolio company for Reed Elsevier Ventures?
- Treato, a company focused on the analysis of prescription drug reviews, is a notable portfolio company for Reed Elsevier Ventures.
- What stages of investment does Reed Elsevier Ventures typically engage in?
- Reed Elsevier Ventures has participated in both A Round and B Round investments, including follow-on rounds.
- When did Reed Elsevier Ventures make its most recent investments?
- Reed Elsevier Ventures made investments in December 2012 and April 2013.
- What was the investment range for Reed Elsevier Ventures?
- Reed Elsevier Ventures' investment range was between $5.5M and $14.5M.
- What was the last known funding round for Treato that Reed Elsevier Ventures participated in?
- Reed Elsevier Ventures participated in a $20M funding round for Treato.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2000 |
|---|